Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 4/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GRN | P28799 | 1/20 | 0.33 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.33 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.33 |
| ▸ | GLS | O94925 | 1/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21784435 | 0.89 | CNR2 (0.37) | ADORA2AADORA2BLMNABCHEALDH1A1 | |
| SCHEMBL18415022 | 0.86 | CNR2 (0.41) | CNR1CNR2 | |
| SCHEMBL21784450 | 0.85 | BCHE (0.35) | ADORA2AADORA2BLMNABCHEALDH1A1 | |
| SCHEMBL21784458 | 0.82 | CNR2 (0.32) | CNR1CNR2 | |
| SCHEMBL19258507 | 0.80 | KDM4E (0.35) | ADORA2AADORA2BKDM4EGRNSORT1 | |
| SCHEMBL18415108 | 0.80 | CNR2 (0.35) | BCHECNR1CNR2 | |
| SCHEMBL21719697 | 0.80 | CNR2 (0.35) | BCHECNR1CNR2 | |
| SCHEMBL21784433 | 0.78 | CNR2 (0.34) | CNR1CNR2 | |
| SCHEMBL21767220 | 0.77 | BCHE (0.35) | LMNABCHEALDH1A1KDM4EGRN | |
| SCHEMBL18415064 | 0.76 | BCHE (0.30) | BCHECNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11771677-B2 | Immunomodulating urea azalides | ZOETIS SERVICES LLC (US) | 2023-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11771677-B2 | Immunomodulating urea azalides | ARG1, IL2, CD209 | ADORA2A 577/4885ADORA2B 801/4885LMNA 4881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.